MedTrace Logo

Physical Exercise for Colorectal Cancer Patients After Transanal Total Mesorectal Excision

NCT03120104 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-04-19

No results posted yet for this study

Summary

Fecal incontinence is common in patients with rectal cancer after surgery. Previous studies showed that pelvic floor muscle and external sphincter muscle training after stoma closure could improve the severity of incontinence and other fecal symptoms, but there is no study about the effects of pelvic floor muscle exercise intervention before stoma closure. We are wondering would the symptom of fecal incontinence recover sooner and better if we give the pelvic floor muscle exercise intervention before the stoma closure. This article aims at comparing the effects of pelvic floor muscle training before stoma closure on fecal incontinence (pre-intervention group) with pelvic floor muscle training after stoma closure (post-intervention group), and we hypothesise that the severity of fecal incontinence will improve sooner and better in pre-intervention group.

Conditions

Interventions

OTHER

pelvic floor muscle exercise before stoma closure

pelvic floor muscle training for one month (2\~3 times a week, for 4 weeks) just one month before the stoma closure

OTHER

pelvic floor muscle exercise after stoma closure

pelvic floor muscle training for one month (2\~3 times a week, for 4 weeks) just two weeks after the stoma closure

Sponsors & Collaborators

  • Taipei Medical University WanFang Hospital

    lead OTHER

Principal Investigators

  • Pin Li · Rehabilitation Department of Taipei Municipal WanFang Hospitial (Managed by Taipei Medical University)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-30
Primary Completion
2018-12-31
Completion
2019-02-28

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03120104 on ClinicalTrials.gov